From three months to 24 months, the regression is quite minimal. Patients should be reminded that they will be experiencing temporary dryness for approximately one week and may notice halos and glare around lights at night during this time. Instructions should also include an explanation of fluctuating vision, especially in the first two weeks and of lesser degree in the first few months. Depending on treatment and target, help the patient understand the normalcy of the myopic overshoot and its importance for an optimal outcome. By the week-one visit, the foreign body sensation and photophobia have ended, the mild fluctuating vision begins to subside, and the patient has begun to adapt to the surgically induced monovision.
Spots are markedly visible with no overlying necrotic tissue.
Deep striae still remain. At this point the treatment spots are no longer visible with the naked eye. The three-month visit is simply to confirm the final prescription. You will also notice that the holmium spots are barely visible. Most patients will initially experience a myopic overcorrection resulting in good near vision but poor distance correction and need to be educated about this prior to surgery.